Supriya Lifescience Ltd.

Headquartered in Mumbai, India We are a Pure Play API Manufacturer & Suppliers

Leadership

Significant scale with leadership position in our therapeutic segments

Growing
Alliances

Global presence over 85+ countries with a growing customer base & establishing CDMO partnership

About Us

Supriya Lifescience Limited headquartered in Mumbai, India is a public listed generic pharmaceutical company established in 1987 dedicated to developing, commercializing APIs & FDFs to treat patients with various diseases and infections. The API facility located at Lote, Maharashtra, India is multiple times USFDA, EDQM/EUGMP approved, and Health Canada approved.

Watch Video

Area of Focus

API

FDF

CDMO

40+

Products

86+

Countries

1500+

Customers

22%

& above CAGR since 2019

400+

Employee Strength

We have a global footprint that extends across 86 countries

APIs

FDF

Awards

Latest News

28 May 2025

Supriya Lifescience aims for 20% annual revenue growth with steady margins

28 May 2025

Supriya Lifescience Reports Strong Financial Performance Amid Evaluation Adjustment in March 2025

28 May 2025

Supriya Lifescience standalone net profit rises 36.42% in the March 2025 quarter

26 May 2025

Saloni Wagh, Aman Mehta, Aalok Shanghvi, Vidhi Shanghvi: Meet the young minds steering India’s pharma giants

20 May 2025

Supriya Lifescience Meets 70% of its Power Requirement Through Solar Energy

19 May 2025

How India Can Lead the Global Shift in API Self-Reliance Amid Tariff Pressures

21 March 2025

Supriya Lifescience Powers Ahead With New 5 MWp Solar Facility

20 March 2025

Supriya Lifescience Powers Ahead With A New 5 MWp Solar Facility

Several awards for excellence and outstanding performance.

Established in the year 1987, Supriya Lifescience Ltd. is a global leading manufacturer of Active pharmaceutical Ingredients. Our state-of-the-art facility is certified by USFDA, EDQM, EUGMP, NMPA & Health Canada. Facility is located in Khed, District Ratnagiri and headquartered in Mumbai, India.